QA: Esperion Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434868_2021_Esperion_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001434868, Esperion Therapeutics Inc

  xvar xval
0 AssetsCurrent 345,896,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,276,000
3 remainder_Assets 6,086,000
4 LiabilitiesCurrent 94,069,000
5 LiabilitiesNoncurrent 4,744,000
6 remainder_Liabilities 350,579,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 868,163,601
9 ResearchAndDevelopmentExpense 118,502,259
10 remainder_Expenses 109,665,883
11 remainder_Revenues 314,253,473
12 remainder_NetIncome 2,363,506
13 remainder_ComprehensiveNetIncome 166,522
  yvar yval
0 Assets 353,258,000
1 Liabilities 449,392,000
2 Expenses 1,096,331,743
3 Revenues 314,253,473
4 StockholdersEquity -96,134,000
5 NetIncome -779,714,764
6 ComprehensiveNetIncome -779,631,503
7 BaseVar 1,107,882,622
8 EconomicCapitalRatiobeforeLimitedLiability -2.46
9 EconomicCapitalRatio 0.868

Edgar->Model Mapping

Feature Distribution

Change over Time